Trillium Therapeutics (TRIL) Prices 2.75M Shares at $5, Prices 3.25M Convertible Preferred Shares
Tweet Send to a Friend
Trillium Therapeutics (NASDAQ: TRIL) announced that it has priced its previously announced underwritten public offering of 2,750,000 common shares and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE